dfmo reduced putrescine and spermidine levels in b16-f10 melanoma by 98 % and 84 % , respectively , and prolonged the mean survival time from 25.9 +/- 1.2 to 35.7 +/- 2.2 days ( p less than 0.001 ) .
C0034170
putrescine
C0037871
levels